
Limmi is an AI startup founded in 2022, dedicated to transforming patient outcomes by rapidly discovering hidden patterns in life sciences data and turning them into actionable insights. Their platform utilizes cutting-edge AI and deep learning methodologies, built specifically for healthcare and biotech, to offer customers real-time predictions and insights. Unlike many competitors, Limmi's technology is HIPAA and FDA compliant from inception, ensuring the protection of sensitive patient information. The platform allows for automated import and cleaning of clinical data, analysis of multi-modal data using over 60 statistical models, and accelerates drug and biomarker discovery. They claim to reduce data cleanup time to as little as one week, drastically cutting down the time from opaque data to insights. Limmi serves doctors and patients, with claims of 200,000 patients benefiting and 50 doctors using the platform. The company has a leadership team with a combined 128 years of experience in data and artificial intelligence products.

Limmi is an AI startup founded in 2022, dedicated to transforming patient outcomes by rapidly discovering hidden patterns in life sciences data and turning them into actionable insights. Their platform utilizes cutting-edge AI and deep learning methodologies, built specifically for healthcare and biotech, to offer customers real-time predictions and insights. Unlike many competitors, Limmi's technology is HIPAA and FDA compliant from inception, ensuring the protection of sensitive patient information. The platform allows for automated import and cleaning of clinical data, analysis of multi-modal data using over 60 statistical models, and accelerates drug and biomarker discovery. They claim to reduce data cleanup time to as little as one week, drastically cutting down the time from opaque data to insights. Limmi serves doctors and patients, with claims of 200,000 patients benefiting and 50 doctors using the platform. The company has a leadership team with a combined 128 years of experience in data and artificial intelligence products.
Founded: 2022 (San Diego, California area)
Product: AI-powered, no-code data & analytics platform for healthcare/life sciences with built-in traceability and regulatory compliance
Compliance: Claims FDA and HIPAA compliance from inception
Funding: Seed round announced Oct 2023 led by Vinergy Capital (deal for up to $862,500 cash for up to 4% equity)
Founders / Leadership: Co-founders Bryan Ivory (President & CTO) and Trevor Vieweg (Chairman of the Board)
Platform capabilities: Automated data import/cleaning, multimodal analysis (genetic, longitudinal), 60+ models; claims faster data cleanup (as little as one week)
Healthcare and life sciences data analytics; accelerating insights from clinical, genetic, and longitudinal data to support disease detection and research.
2022
Healthcare; Life Sciences; Artificial Intelligence
Up to $862,500 (cash to acquire up to 4% equity)
Agreement includes IP licensing from Limmi to Vinergy in connection with the investment.
“Seed investment/collaboration with Vinergy Capital; Vinergy to acquire up to 4% equity for up to $862,500 and entered an IP licensing arrangement”